Robert F. Kennedy Jr. Plans to Continue Earning from Vaccine Litigation Amid HHS Secretary Nomination
Robert F. Kennedy Jr., HHS Secretary nominee, aims to maintain financial ties to litigation against Merck despite potential conflicts of interest.
Overview
Robert F. Kennedy Jr., nominated as HHS Secretary by President Trump, seeks to continue collecting fees from Wisner Baum, a law firm suing Merck over the Gardasil vaccine. This decision raises ethics concerns due to his ongoing financial interest in vaccine-related lawsuits while regulating the pharmaceutical industry, prompting scrutiny in his upcoming Senate confirmation hearing. Kennedy disclosed significant earnings, including $856,559 from the law firm, and plans to divest from other investments, but intends to keep a role in non-U.S. related cases.
Content generated by AI—learn more or report issue.
Get both sides in 5 minutes with our daily newsletter.
Analysis
Analysis unavailable for this viewpoint.
Articles (6)
Center (4)
No highlight available for this article.
NPR·5M·No highlight available for this article.
Associated Press·5M·No highlight available for this article.
The Hill·5M·No highlight available for this article.
Axios·5M·History
- 5M3 articles